Treatment of Extrahepatic Manifestations of Hepatitis C Virus

• Published in: Clinics in liver disease Vol. 21; no. 3; p. 631
• Main Authors: Degasperi, Elisabetta, Aghemo, Alessio, Colombo, Massimo
• Format: Journal Article
• Language: English
• Published: United States 01.08.2017
• Subjects: Antiviral Agents - adverse effects; Antiviral Agents - therapeutic use; Cognition; Cryoglobulinemia - drug therapy; Cryoglobulinemia - virology; Diabetes Mellitus, Type 2 - prevention & control; Hepacivirus; Hepatitis C, Chronic - complications; Hepatitis C, Chronic - drug therapy; Humans; Interferons - adverse effects; Lymphoproliferative Disorders - drug therapy; Lymphoproliferative Disorders - virology; Quality of Life; Renal Insufficiency - drug therapy; Renal Insufficiency - physiopathology; Renal Insufficiency - virology; Vasculitis - drug therapy; Vasculitis - virology; Cryoglobulinemia; Chronic kidney disease; HCV; Lichen planus; Lymphoma; Sofosbuvir; Direct-acting antivirals; IFN-free regimens

Chronic infection with hepatitis C virus (HCV) is a multifaceted disease characterized by many extrahepatic manifestations (EHMs) that affect outcome and quality of life. HCV eradication by antiviral treatment has been proved beneficial in preventing the development of EHMs and is also able to impro...